Beyond UHC: Monitoring Health and Social Protection Coverage in the Context of Tuberculosis Care and Prevention

English version České info

Tuberculosis (TB) remains a major global public health problem. In all societies, the disease affects the poorest individuals the worst. A new post-2015 global TB strategy has been developed by WHO, which explicitly highlights the key role of universal health coverage (UHC) and social protection. One of the proposed targets is that “No TB affected families experience catastrophic costs due to TB.” High direct and indirect costs of care hamper access, increase the risk of poor TB treatment outcomes, exacerbate poverty, and contribute to sustaining TB transmission. UHC, conventionally defined as access to health care without risk of financial hardship due to out-of-pocket health care expenditures, is essential but not sufficient for effective and equitable TB care and prevention. Social protection interventions that prevent or mitigate other financial risks associated with TB, including income losses and non-medical expenditures such as on transport and food, are also important. We propose a framework for monitoring both health and social protection coverage, and their impact on TB epidemiology. We describe key indicators and review methodological considerations. We show that while monitoring of general health care access will be important to track the health system environment within which TB services are delivered, specific indicators on TB access, quality, and financial risk protection can also serve as equity-sensitive tracers for progress towards and achievement of overall access and social protection.

Vyšlo v časopise: Beyond UHC: Monitoring Health and Social Protection Coverage in the Context of Tuberculosis Care and Prevention. PLoS Med 11(9): e32767. doi:10.1371/journal.pmed.1001693
Kategorie: Collection Review
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001693

Souhrn

Zdroje

1. WHO Sixty-Seventh World Health Assembly (2014). Global strategy and targets for tuberculosis prevention, care and control after 2015. A67/11. Geneva: World Health Organization.

2. WHO (2013) Global tuberculosis report 2013. WHO/HTM/TB/2013.11. Geneva: World Health Organization

3. FalzonD, JaramilloE, WaresF, ZignolM, FloydK, et al. (2013) Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data. Lancet Infect Dis 13: 690–697.

4. RaviglioneM, MaraisB, FloydK, LönnrothK, GetahunH, et al. (2012) Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet 19: 1902–13.

5. LaxminarayanR, KleinEY, DarleyS, AdeyiO (2009) Global investments in TB control: economic benefits. Health Aff 28: 730–742.

6. Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, et al.., eds. (2006) Disease control priorities in developing countries, 2nd edn. New York: Oxford University Press and The World Bank.

7. FloydK, FitzpatrickC, PantojaA, RaviglioneM (2002) Domestic and donor financing for tuberculosis care and control in low-income and middle-income countries: an analysis of trends, 2002—11, and requirements to meet 2015 targets. Lancet Glob Health 1: e105–e115.

8. StorlaDG, YimerS, BjuneGA (2008) A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health 8: 15.

9. MauchV, BonsuF, GyapongM, AwiniE, SuarezP, et al. (2013) Free tuberculosis diagnosis and treatment are not enough: patient cost evidence from three continents. Int J Tuberc Lung Dis 17: 381–387.

10. UkwajaKN, ModebeO, IgwenyiC, AlobuI (2012) The economic burden of tuberculosis care for patients and households in Africa: a systematic review. Int J Tuberc Lung Dis 16: 733–739.

11. WHO (2008) Contributing to health system strengthening - Guiding principles for national tuberculosis programmes. WHO/HTM/TB/2008.400. Geneva: World Health Organization

12. AtunR, WeilDEC, Tan EangM, MwakyusaD (2010) Health-system strengthening and tuberculosis control. Lancet 19: 2169–78.

13. TanimuraT, JaramilloE, WeilD, RaviglioneM, LönnrothK (2014) Financial burden for tuberculosis patients in low- and middle-income countries – a systematic review. Eur Respir J 43: 1763–1775.

14. LongQ, SmithH, ZhangT, TangS, GarnerOP (2011) Patient medical costs for tuberculosis treatment and impact on adherence in China: a systematic review. BMC Public Health 11: 393.

15. WingfieldT, BocciaD, TovarM, GavinoA, ZevallosK, et al. (2014) Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru. PLoS Med 11: 1001675.

16. LönnrothK, JaramilloE, WilliamsBG, DyeC, RaviglioneM (2009) Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 68: 2240–2246.

17. StorlaDG, YimerS, Bjune GA (2008) A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health 8: 15.

18. Hirsch-MovermanY, DaftaryA, FranksJ, ColsonPW (2008) Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada. Int J Tuberc Lung Dis 12: 1235–1254.

19. MunroSA, LewinSA, SmithH, EngelME, FretheimA, et al. (2007) Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med 4: e238.

20. WaittCJ, SquireSB (2001) A systematic review of risk factors for death in adults during and after tuberculosis treatment. Int J Tuberc Lung Dis 15: 871–885.

21. WHO (2010) World Health Report 2010: health systems financing - the path to universal coverage. Geneva: World Health Organization

22. International Labour Office (2009) A joint Crisis Initiative of the UN Chief Executives Board for Co-ordination on the social protection floor. Geneva: International Labour Organization.

23. International Labour Office (2010) World Social Security Report 2010/11: providing coverage in times of crisis and beyond. Geneva: ILO.

24. Rockefeller Foundation, Save the Children, UNICEF, World Health Organization (2013) Universal health coverage: a commitment to close the gap. London: Save the Children

25. VolminkJ, GarnerP (1997) Systematic review of randomised controlled trials of strategies to promote adherence to tuberculosis treatment. BMJ 315: 1403–6.

26. RochaC, MontoyaR, ZevallosK, CuratolaA, YngaW, et al. (2011) The Innovative Socio-economic Interventions Against Tuberculosis (ISIAT) project: an operational assessment. Int J Tuberc Lung Dis 15: S50–S57.

27. WeiX, ZouG, YinJ, WalleyJ, YangH, et al. (2012) Providing financial incentives to rural-to-urban TB migrants in Shanghai: an intervention study. Infect Dis Poverty 1: 9.

28. ToczekA, CoxH, du CrosP, CookeG, FordN (2012) Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis 17: 299–307.

29. SripadA, CastedoJ, DanfordN, ZahaR, FreileC (2014) Effects of Ecuador's national monetary incentive program on adherence to treatment for drug-resistant tuberculosis. Int J Tuberc Lung Dis 18: 44–48.

30. BaralSC, AryalY, BhattraiR, KingR, NewellJN (2014) Effects of Ecuador's national monetary incentive program on adherence to treatment for drug-resistant tuberculosis. BMC Public Health 14: 46.

31. RichterL, LönnrothK, DesmondC, JacksonR, JaramilloE, et al. (2014) Economic support to patients in HIV and TB grants in Rounds 7 and 10 from the Global Fund to Fight AIDS, Tuberculosis and Malaria. PLoS ONE 9: e86225.

32. RaviglioneM, KrechR (2011) Tuberculosis: still a social disease. Int J Tuberc Lung Dis 15: S6–S8.

33. WHO (2013) Eliminating the Catastrophic Economic Burden of TB: Universal Health Coverage and Social Protection Opportunities - report of a global consultation. Geneva: World Health Organization. Available: www.who.int/tb/uhc_socialprotection/en Accessed 14 November 2013.

34. RasanathanK, SivasankaraAK, Jaramillo E. LönnrothK (2011) The social determinants of health: key to global tuberculosis control. Int J Tuberc Lung Dis 15: S30–36.

35. WHO (2013) World health report 2013: research for universal health coverage. Geneva: World Health Organization.

36. DyeC, MaherD, WeilD, EspinalM, RaviglioneM (2006) Targets for global tuberculosis control. Int J Tuberc Lung Dis 10: 460–462.

37. BoermaT, AbouZahrC, EvansD, EvansT (2014) Monitoring intervention coverage in the context of universal health coverage. PLoS Med 11: e1001728..

38. WHO (1994) Framework for effective tuberculosis control. WHO/TB/94.179. Geneva: World Health Organization

39. WHO (2002) An expanded DOTS framework for effective tuberculosis control. WHO/CDS/TB/2002.297. Geneva: World Health Organization

40. WHO (2006) Revised TB recording and reporting forms and registers—version 2006. WHO/HTM/TB/2006.373. Geneva: World Health Organization

41. Styblo K, Bumgarner JR (1991) Tuberculosis can be controlled with existing technologies: evidence. The Hague: Tuberculosis Surveillance Research Unit.

42. DyeC, GarnettGP, SleemanK, WilliamsBG (1998) Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed shortcourse therapy. Lancet 352: 1886–1891.

43. WHO (1991) Forty-fourth World Health Assembly, Resolutions and Decisions. Resolution WHA 44.8. Geneva: World Health Organization.

44. Millennium Project (2006) Goals, targets and indicators. Available: http://www.unmillenniumproject.org/goals/gti.htm. Accessed 16 October 2013.

45. WHO (2006) The Stop TB Strategy. WHO/HTM/TB/2006.368. Geneva: World Health Organization

46. WHO (2006) Engaging all health care providers in TB control - guidance on implementing public-private mix approaches. WHO/HTM/TB/2006.360. Geneva: World Health Organization

47. WHO (2003) Practical tools for involvement of private providers in TB control - A guide for NTP-managers. WHO/CDS/TB/2003.325. Geneva: World Health Organisation

48. BassiliA, Al-HammadiA, Al-AbsiA, GlaziouP, SeitaA, et al. (2013) Estimating the tuberculosis burden in resource-limited countries: a capture-recapture study in Yemen. Int J Tuberc Lung Dis 17: 456–461.

49. HuseynovaS, HashimDS, TbenaMR, HarrisR, BassiliA, et al. (2013) Estimating tuberculosis burden and reporting in resource-limited countries: a capture-recapture study in Iraq. Int J Tuberc Lung Dis 17: 462–467.

50. van LethF, van der WerfMJ, BorgdorffMW (2008) Prevalence of tuberculous infection and incidence of tuberculosis: a re-assessment of the Styblo rule. Bull World Health Organ 86: 20–26.

51. World Health Organization (2006) The global plan to stop TB 2006–2015. Available: www.who.int/tb/features_archive/global_plan_to_stop_tb/en/index.html Accessed 14 November 2013.

52. Colijn C, Cohen T, Murray M (2006) Mathematical Models of Tuberculosis: accomplishments and future challenges. In: Proceedings of the International Symposium on Mathematical and Computational Biology. World Scientific; Manaus, Brazil, 27–30 November 2006. Available: http://www.worldscientific.com/doi/abs/10.1142/9789812708779_0008?queryID=%24%7BresultBean.queryID%7D&

53. DyeC, BassiliA, BierrenbachA, BroekmansJF, ChadhaVK, et al. (2008) Measuring tuberculosis burden, trends, and the impact of control programmes. Lancet Infect Dis 8: 233–243.

54. World Health Organization (2011) Tuberculosis prevalence surveys: a handbook. WHO/HTM/TB/2010.17. Geneva, World Health Organization.

55. WHO (2014) Standards and benchmarks for tuberculosis surveillance and vital registration systems: checklist and user guide. (WHO/HTM/TB/2014.02). Geneva: World Health Organization. Available: http://www.who.int/iris/bitstream/10665/112673/1/9789241506724_eng.pdf

56. WHO (2009) WHO guide to identifying the economic consequences of disease and injury. Geneva: World Health Organization

57. RansonMK (2002) Reduction of catastrophic health care expenditures by a community-based health insurance scheme in Gujarat, India: current experiences and challenges. Bull World Health Organ 80: 613–621.

58. TBCTA (2011) The tool to estimate patients' costs. The Hague: Tuberculosis Coalition for Technical Assistance, U.S. Agency for International Development. Available: http://www.tbcare1.org/publications/toolbox/access. Accessed 14 November 2013.

59. WHO (2005) Addressing poverty in TB control. WHO/HTM/TB/2005.352. Geneva: World Health Organization.

60. MuniyandiM, RamachandranR, GopiPG, ChandrasekaranV, SubramaniR, et al. (2007) The prevalence of tuberculosis in different economic strata: a community survey from South India. Int J Tuberc Lung Dis 11: 1042–1045.

61. BocciaD, HargreavesJ, AylesH, FieldingK, SimwingaM, et al. (2009) Tuberculosis infection in Zambia: the association with relative wealth. Am J Trop Med Hyg 80: 1004–1011.

62. HarlingG, EhrlichR, MyerL (2008) The social epidemiology of tuberculosis in South Africa: a multilevel analysis. Soc Sci Med 66: 492–505.